GB9903671D0 - Dopamine D-1 receptor agonist compounds - Google Patents

Dopamine D-1 receptor agonist compounds

Info

Publication number
GB9903671D0
GB9903671D0 GBGB9903671.7A GB9903671A GB9903671D0 GB 9903671 D0 GB9903671 D0 GB 9903671D0 GB 9903671 A GB9903671 A GB 9903671A GB 9903671 D0 GB9903671 D0 GB 9903671D0
Authority
GB
United Kingdom
Prior art keywords
dopamine
receptor agonist
agonist compounds
compounds
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9903671.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paion UK Ltd
Original Assignee
Cenes Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenes Ltd filed Critical Cenes Ltd
Priority to GBGB9903671.7A priority Critical patent/GB9903671D0/en
Publication of GB9903671D0 publication Critical patent/GB9903671D0/en
Priority to AU25632/00A priority patent/AU767332B2/en
Priority to CZ20012973A priority patent/CZ20012973A3/en
Priority to PCT/GB2000/000570 priority patent/WO2000049000A1/en
Priority to CNB00803947XA priority patent/CN1142916C/en
Priority to PL00349838A priority patent/PL349838A1/en
Priority to BR0008329-1A priority patent/BR0008329A/en
Priority to IL14481000A priority patent/IL144810A0/en
Priority to EP00903881A priority patent/EP1157009A1/en
Priority to MXPA01008294A priority patent/MXPA01008294A/en
Priority to CA002363695A priority patent/CA2363695A1/en
Priority to EA200100783A priority patent/EA004745B1/en
Priority to KR1020017010418A priority patent/KR20010108228A/en
Priority to HU0200057A priority patent/HUP0200057A3/en
Priority to JP2000599740A priority patent/JP2002537288A/en
Priority to ZA200106478A priority patent/ZA200106478B/en
Priority to NO20013978A priority patent/NO20013978D0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
GBGB9903671.7A 1999-02-17 1999-02-17 Dopamine D-1 receptor agonist compounds Ceased GB9903671D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9903671.7A GB9903671D0 (en) 1999-02-17 1999-02-17 Dopamine D-1 receptor agonist compounds
JP2000599740A JP2002537288A (en) 1999-02-17 2000-02-17 Dopamine D1 receptor agonist compounds
EP00903881A EP1157009A1 (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds
CA002363695A CA2363695A1 (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds
PCT/GB2000/000570 WO2000049000A1 (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds
CNB00803947XA CN1142916C (en) 1999-02-17 2000-02-17 Dopamine D1 receptor agonist compounds
PL00349838A PL349838A1 (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds
BR0008329-1A BR0008329A (en) 1999-02-17 2000-02-17 D1 dopamine receptor agonist compounds, pharmaceutical composition and their use
IL14481000A IL144810A0 (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds
AU25632/00A AU767332B2 (en) 1999-02-17 2000-02-17 Dopamine D1 receptor agonist compounds
MXPA01008294A MXPA01008294A (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds.
CZ20012973A CZ20012973A3 (en) 1999-02-17 2000-02-17 Agonists of dopamine D1 receptor
EA200100783A EA004745B1 (en) 1999-02-17 2000-02-17 Tetrahydrobenzazepine derivatives as dopamined1 receptors
KR1020017010418A KR20010108228A (en) 1999-02-17 2000-02-17 Dopamine D1 receptor agonist compounds
HU0200057A HUP0200057A3 (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds, pharmaceutical compositions containing them and their use
ZA200106478A ZA200106478B (en) 1999-02-17 2001-08-07 Dopamine D1 receptor agonist compounds.
NO20013978A NO20013978D0 (en) 1999-02-17 2001-08-15 Dopamine D1 receptor agonist compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903671.7A GB9903671D0 (en) 1999-02-17 1999-02-17 Dopamine D-1 receptor agonist compounds

Publications (1)

Publication Number Publication Date
GB9903671D0 true GB9903671D0 (en) 1999-04-14

Family

ID=10847990

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9903671.7A Ceased GB9903671D0 (en) 1999-02-17 1999-02-17 Dopamine D-1 receptor agonist compounds

Country Status (17)

Country Link
EP (1) EP1157009A1 (en)
JP (1) JP2002537288A (en)
KR (1) KR20010108228A (en)
CN (1) CN1142916C (en)
AU (1) AU767332B2 (en)
BR (1) BR0008329A (en)
CA (1) CA2363695A1 (en)
CZ (1) CZ20012973A3 (en)
EA (1) EA004745B1 (en)
GB (1) GB9903671D0 (en)
HU (1) HUP0200057A3 (en)
IL (1) IL144810A0 (en)
MX (1) MXPA01008294A (en)
NO (1) NO20013978D0 (en)
PL (1) PL349838A1 (en)
WO (1) WO2000049000A1 (en)
ZA (1) ZA200106478B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
BRPI0613403A2 (en) * 2005-07-15 2009-02-10 Amr Technology Inc aryl and heteroaryl substituted tetrahydrobenzodiazepines and their use to block reuptake of norepinephrine, dopamine and serotonin
EP1917275A4 (en) * 2005-08-03 2009-01-28 Mineuet Therapeutics Ltd Modulating the kv1.1 voltage-gated potassium channel in t-cells for regulating the synthesis and secretion of tumor necrosis factor (tnf- ) and treating human diseases or injuries mediated by detrimentally high or low levels of tnf-
CN101684096A (en) * 2008-09-23 2010-03-31 中国科学院上海药物研究所 Novel benzoazepine compound and preparation method and application thereof
CN102276531A (en) * 2011-05-30 2011-12-14 扬子江药业集团广州海瑞药业有限公司 Method for preparing fenoldopam mesylate
CU24334B1 (en) 2013-06-27 2018-04-03 Pfizer PIRIDIN-2 CONTAINING IL-4-SUBSTITUTED DERIVATIVES OF 1-DIAZINO PHENYL USEFUL AS LEGANDOS OF DOPAMINE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561305A (en) * 1975-07-02 1980-02-20 Smithkline Corp Benzazepine derivatives and pharmeceutical compositions containing them
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4707483A (en) * 1985-12-20 1987-11-17 Smithkline Beckman Corporation 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders
US4861771A (en) * 1989-01-27 1989-08-29 Smithkline Beckman Corporation Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs

Also Published As

Publication number Publication date
IL144810A0 (en) 2002-06-30
AU2563200A (en) 2000-09-04
ZA200106478B (en) 2002-02-07
HUP0200057A3 (en) 2004-03-29
PL349838A1 (en) 2002-09-23
BR0008329A (en) 2002-01-29
CZ20012973A3 (en) 2002-01-16
KR20010108228A (en) 2001-12-07
EA004745B1 (en) 2004-08-26
NO20013978L (en) 2001-08-15
MXPA01008294A (en) 2002-07-02
EA200100783A1 (en) 2002-02-28
WO2000049000A1 (en) 2000-08-24
HUP0200057A2 (en) 2002-08-28
EP1157009A1 (en) 2001-11-28
NO20013978D0 (en) 2001-08-15
AU767332B2 (en) 2003-11-06
CN1341102A (en) 2002-03-20
CA2363695A1 (en) 2000-08-24
CN1142916C (en) 2004-03-24
JP2002537288A (en) 2002-11-05

Similar Documents

Publication Publication Date Title
NO20013444L (en) Triazole compounds with the dopamine D3 receptor affinity
HUP0203375A3 (en) Substituted oxoazaheterocyclyl compounds
HK1091403A1 (en) 5-ht 1a receptor subtype agonist
SG80041A1 (en) Muscarinic receptor antagonists
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
AU4098501A (en) Estrogen agonist/antagonist metabolites
IL146151A0 (en) Human-g-protein receptor
GB2349882B (en) Dopamine transporter imaging agents
HUP0101746A3 (en) Phenylsulfonamide-phenylethylamines usefull as dopamine receptors
GB9903671D0 (en) Dopamine D-1 receptor agonist compounds
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
EP1520856A4 (en) Androgen receptor agonist
AU6230698A (en) Dopamine d4 receptor antagonist
AU4511901A (en) Nonpeptide kappa opioid receptor antagonists
EP1103734A4 (en) Simplified tightening device
EP1120426A4 (en) Novel g protein-coupled receptors
GB0000474D0 (en) Receptor
AU1252102A (en) Receptor
EP1131335A4 (en) 7tm receptor hlwar77
SI1077935T1 (en) Phenylsulfonamide-phenylethylamines useful as dopamine receptors
GB2356166B (en) Extension device for wheelbraces
GB0130576D0 (en) Dopamine D1 receptor agonist pro-drug compounds & derivatives
GB0107914D0 (en) 7tm receptor hlwar77
TW424568U (en) Improved structure for dust-gathering device
GB0020710D0 (en) Dopamine D1 receptor agonist pro-drug compounds & derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)